Solid Biosciences (SLDB) Other Non Operating Income (2017 - 2026)

Solid Biosciences has disclosed Other Non Operating Income across 10 years of filings, most recently posting $157000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $157000.0, down 16.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $793000.0 (down 5.26% YoY), and the FY2025 annual result was $824000.0, up 26.38% from the prior year.
• Other Non Operating Income came in at $157000.0 for Q1 2026 at Solid Biosciences, down from $219000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $282000.0 in Q1 2023 to a low of -$355000.0 in Q4 2022.
• The 5-year median for Other Non Operating Income is $207000.0 (2025), against an average of $138058.8.
• Across the five-year window, Other Non Operating Income plunged 200.0% in 2022 and jumped 8933.33% in 2023, its largest moves.
• Solid Biosciences' Other Non Operating Income stood at -$355000.0 in 2022, then jumped by 176.06% to $270000.0 in 2023, then retreated by 26.3% to $199000.0 in 2024, then climbed by 10.05% to $219000.0 in 2025, then slipped by 28.31% to $157000.0 in 2026.
• The last three Other Non Operating Income figures came in at $157000.0 (Q1 2026), $219000.0 (Q4 2025), and $210000.0 (Q3 2025), per Business Quant data.